Interesting question.
How is the problem of stock handled when a drug is suddenly withdrawn?
Logistically? Presumably the wholesalers and pharmacists holding stock
have to destroy it or return it to the manufacturers.. At whose expense?
Accountancy - who takes the financial loss?
Communications? Who is responsible for informing patients?
Legally. Does world-wide withdrawal by the manufacturers *automatically*
stop it being a "medicine" under national legislation - here or
elsewhere? And is any such legislation EU, UK, or devolved?
MaryH
In message <002e01c4a73a$5fa9c5c0$0d00000a@dylan>, Jeff Green
<[log in to unmask]> writes
>A hypothetical question ;-)
>
>With the worldwide withdrawal of Vioxx presumably it's license is now
>revoked. At this point is it no longer a medicine? (as
>defined in law as opposed to reality)
>
>Or to put it another way - would it be illegal (as opposed to
>unethical) to sell my existing stocks on e-bay as "collectors
>items"
>
>
>Regards
>
>Jeff
>
--
Mary Hawking
|